A new look at osteoporosis outcomes: the influence of treatment, compliance, persistence, and adherence.

Suppr

超能文献

作者信息

Badamgarav Enkhe, Fitzpatrick Lorraine A

出版信息

Mayo Clin Proc. 2006 Aug;81(8):1009-12. doi: 10.4065/81.8.1009.

DOI:10.4065/81.8.1009

PMID:16901022

Abstract

摘要

相似文献

A new look at osteoporosis outcomes: the influence of treatment, compliance, persistence, and adherence.

Mayo Clin Proc. 2006 Aug;81(8):1009-12. doi: 10.4065/81.8.1009.

Adherence and persistence: impact on outcomes and health care resources.

Bone. 2006 Feb;38(2 Suppl 2):S18-21. doi: 10.1016/j.bone.2005.11.013. Epub 2006 Jan 27.

How to prevent glucocorticoid-induced osteoporosis.

Cleve Clin J Med. 2010 Aug;77(8):529-36. doi: 10.3949/ccjm.77a.10003.

The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis.

Expert Rev Pharmacoecon Outcomes Res. 2012 Apr;12(2):159-66. doi: 10.1586/erp.12.8.

Persistence with bisphosphonate treatment for osteoporosis: finding the root of the problem.

Am J Med. 2006 Apr;119(4 Suppl 1):S12-7. doi: 10.1016/j.amjmed.2005.12.018.

How can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosphonate therapy.

Ann Pharmacother. 2006 Jun;40(6):1143-50. doi: 10.1345/aph.1G534. Epub 2006 May 30.

Improving compliance and persistence with bisphosphonate therapy for osteoporosis.

Am J Med. 2006 Apr;119(4 Suppl 1):S18-24. doi: 10.1016/j.amjmed.2005.12.019.

Potential clinical and economic impact of nonadherence with osteoporosis medications.

Calcif Tissue Int. 2010 Mar;86(3):202-10.

Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis.

Mayo Clin Proc. 2007 Dec;82(12):1493-501. doi: 10.1016/S0025-6196(11)61093-8.

Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.

Clin Ther. 2007 Sep;29(9):2055-67. doi: 10.1016/j.clinthera.2007.09.024.

引用本文的文献

Evaluating adherence, tolerability and safety of oral calcium citrate in elderly osteopenic subjects: a real-life non-interventional, prospective, multicenter study.

Aging Clin Exp Res. 2024 Feb 12;36(1):38. doi: 10.1007/s40520-024-02696-9.

Analysis of Influencing Factors of Medication Compliance in Patients with Recurrent Vertebral Fractures after Percutaneous Kyphoplasty and the Role of Family-Centered Education Intervention.

Evid Based Complement Alternat Med. 2021 Oct 22;2021:3974674. doi: 10.1155/2021/3974674. eCollection 2021.

Adherence and preference of intravenous zoledronic acid for osteoporosis versus other bisphosphonates.

Eur J Hosp Pharm. 2019 Jan;26(1):4-9. doi: 10.1136/ejhpharm-2017-001258. Epub 2017 Sep 20.

Denosumab: a review of its use in postmenopausal women with osteoporosis.

Drugs Aging. 2014 Jul;31(7):555-76. doi: 10.1007/s40266-014-0191-3.

Characteristics associated with bone mineral density responses to alendronate in men.

Calcif Tissue Int. 2013 Jun;92(6):548-56. doi: 10.1007/s00223-013-9715-9. Epub 2013 Mar 15.

Factors affecting adherence to osteoporosis medications: a focus group approach examining viewpoints of patients and providers.

J Geriatr Phys Ther. 2011 Apr-Jun;34(2):72-81. doi: 10.1097/JPT.0b013e3181ff03b4.

[Osteoporosis treatment with biphosphonates: Approaches to care reality].

Aten Primaria. 2011 Feb;43(2):95-9. doi: 10.1016/j.aprim.2010.04.008. Epub 2010 Jun 11.

Treatment of postmenopausal osteoporosis, patient perspectives - focus on once yearly zoledronic acid.

Patient Prefer Adherence. 2009 Nov 3;3:189-93. doi: 10.2147/ppa.s3494.

Patient decision to initiate therapy for osteoporosis: the influence of knowledge and beliefs.

J Gen Intern Med. 2008 Nov;23(11):1815-21. doi: 10.1007/s11606-008-0772-0. Epub 2008 Sep 12.

Bisphosphonates in the management of postmenopausal osteoporosis--optimizing efficacy in clinical practice.

Clin Interv Aging. 2008;3(2):279-97. doi: 10.2147/cia.s2134.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验